While both interventions provided benefits, there was no difference in the results observed between the two. More research is required to determine how these may be potentially integrated into the management plans of people living with MS. [2/2]

Congrats to Prof Jeannette Lechner-Scott (@Uni_Newcastle) on being @MS_Australia’s 2024 #MultipleSclerosis Research Award winner. Her work has helped shape our understanding of the development & treatment of #MS over many decades.

Our friends at @ResearchMenzies have created another fantastic online resource for people living with #MultipleSclerosis. This free program aims to improve understanding of #mentalhealth & how it’s linked to #MS.

VOTE NOW: I would like to better understand how the immune system works and what goes wrong in an autoimmune disease, such as #MultipleSclerosis #MS #Poll

While more data is needed, especially in people living with #MultipleSclerosis, this suggests that yoga may have both physical & mental health benefits, as well as improve quality of life. Those wanting more detail about this review can find it here: [2/2]

While this requires much further testing, it is another positive step forward towards the goal of having an effective treatment that is able to reverse the damage caused to the myelin sheath in MS. The published paper in question can be read here: [2/2]

As we know this trial is of great interest to the MS community, we will endeavour to share outcomes from it as soon as they become available. [2/2]

Anyone wanting to read about this work in more detail can do so here: [2/2]

While people living with MS have higher levels of many psychological conditions overall, this research suggests that there needs to be greater awareness of these issues during pregnancy.

Fatigue is a challenge for most living with #MultipleSclerosis & has a significant impact on quality of life. This new @ECTRIMS Podcast episode shares the latest fatigue research & discusses how the identification & treatment of fatigue needs to change.

The @US_FDA has issued a warning about the risk of a rare but serious allergic reaction with the #MultipleSclerosis medicine, glatiramer acetate (Copaxone, Glatopa). If you have any concerns about this, contact your healthcare professional to discuss. #MS

More detail on Cambridge's current research can be found below. We expect that #clinicaltrials testing the ability of specific fasting protocols to repair myelin in people living with MS will also be conducted by research groups in the future. [2/2]

Another trial for remyelination in #MultipleSclerosis has been approved. It’s exciting to see that myelin repair is being investigated from a number of different angles, as this increases the chances of an effective therapy being discovered. #MS